Application
Immunofluorescence analysis of HepG2 cells, using ERGI3 Antibody. The picture on the right is treated with the synthesized peptide.Application
Western blot analysis of extracts from LOVO/NIH-3T3 cells, using ERGI3 Antibody. The lane on the right is treated with the synthesized peptide.| Product Name | ERGI3 antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Rabbit polyclonal antibody to ERGI3Possible role in transport between endoplasmic reticulum and Golgi. |
| Immunogen | The antiserum was produced against synthesized peptide derived from human ERGI3. |
| Clonality | Polyclonal |
|---|---|
| Host Species | Rabbit |
| Tested Applications | ELISAICC/IFWB |
| IF: 1:100~1:500 : |
|
| Species Reactivity | HumanMouse |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Synonyms | ERGIC3 NYBR84 Erv46 Serologically defined breast cancer antigen NYBR84 ERGI3 Serologically defined breast cancer antigen NY-BR-84 NY-BR-84 ERGIC and golgi 3 ERGIC and golgi3 NY BR 84 |
|---|---|
| Target | ERGI3 |
| Molecular Weight(MW) | 43 kDa (note) |
| Tissue Specificity | ERGI3 Antibody detects endogenous levels of total ERGI3 protein. |
| Cellular Localization | Cycles between the endoplasmic reticulum and the Golgi. |
Application
Immunofluorescence analysis of HepG2 cells, using ERGI3 Antibody. The picture on the right is treated with the synthesized peptide.
Application
Western blot analysis of extracts from LOVO/NIH-3T3 cells, using ERGI3 Antibody. The lane on the right is treated with the synthesized peptide.| Application Notes | IF: 1:100~1:500 : |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Store at -20 degrees Celcius. Product is stable for at least 1 year. |
| Storage Buffer | Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
